Faculty

Institution

Unit

Venue

Takuya Osada

Adjunct Associate Professor

Duke University

Affiliations

School of Medicine

Clinical Science Departments

Department of Surgery

Division of Surgical Sciences

Takuya Osada is currently serving as a Clinical Science S Adjunct Associate Professor at Duke University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Takuya Osada

Duke University

Adjunct Associate Professor

You can click a keyword to filter the displayed items

oncology immunology cancer research cancer immunotherapy medicinal research cancer biology medicine cancer treatment pharmacology immunotherapy cancer care tumor biology breast cancer clinical research cellular therapy cell biology clinical immunology tumor targeting cancer cells immune responses colorectal cancer cancer imaging oncogenes adaptive immune system molecular cancer enzyme inhibition breast oncology viral oncology surgical oncology cell regulation anti-cancer agents pharmacotherapy leukemia vaccine research vascular biology cancer genetics immunomodulation cancer genomics cancer discovery cancer growth immune checkpoint inhibitors tumor suppressors experimental medicine cancer risk t-regulatory cell clinical mycology cellular immune responses cancer immunosurveillance signaling pathways dendritic cells clinical investigation thoracic oncology liver cancer gastrointestinal oncology hematological malignancies drug targeting hepatocellular carcinoma molecular immunology therapeutic efficacy apoptosis prognostic evaluation cancer patients cancer vaccines antigen-specific immune responses costimulatory molecules carcinoembryonic antigen alphavirus vector surgical resection glutamine synthetase expression antibody responses physiological shear flow colon cancer cells tumor protein intratumoral immunotherapy dexosome immunotherapy dendritic cell-based immunotherapy

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 4297: Cox-2/Pge2 Driven, Photoimmunotherapy-Induced Edema is Reduced by Prophylactic Nsaids in Mouse Tumor Models. Cancer Research (2026)

A Precision Ultrasound-Localized Sonoporation-Equipment (Pulse) Enabling Intratumoral Delivery for Cancer Immunotherapy. bioRxiv (Cold Spring Harbor Laboratory) (2025)

cancer immunotherapyultrasoundcancer imagingmedical ultrasoundbiomedical engineering

Abstract 1415: Reduction in Photoimmunotherapy-Induced Edema With Cox-2 Inhibition: Combatting Clinically Relevant Adverse Events Without Compromising Efficacy. Cancer Research (2024)

Gina MaMyra GordonJason LapetodaAbram LozanoChristopher M. AmanteaTakuya OsadaAmy H. Thorne

photoimmunotherapy-induced edemacancer immunotherapymedicineoncologycancer researchrelevant adverse eventsimmunologyphotomedicineclinical researchmedicinal researchtreatment options

Clinical Trials of Self-Replicating Rna-Based Cancer Vaccines. Cancer Gene Therapy (2023)

Michael A. MorseErika J. CrosbyJeremy ForceTakuya OsadaAmy C. HobeikaZachary C. HartmanPeter BerglundJonathan SmithH. Kim Lyerly

medicineoncology

Data From I in Vivo /I Detection of Hsp90 Identifies Breast Cancers With Aggressive Behavior. (2023)

Takuya OsadaKensuke KanekoWilliam R. GwinMichael A. MorseAmy HobeikaBrian W. PogueZachary C. HartmanPhilip F. HughesTimothy HaysteadH. Kim Lyerly

cancer genomicsmolecular diagnosticsgeneticsmicroarray data analysiscancer imagingcancer researchoncologyin vivo systemscancer biologybiostatisticsmolecular biologycarcinogenesisbreast cancercancer detectionmedicinal research

Data From Phase I Study Utilizing a Novel Antigen-Presenting Cell–Targeted Vaccine With Toll-Like Receptor Stimulation to Induce Immunity to Self-Antigens in Cancer Patients. (2023)

Michael A. MorseRobert ChapmanJohn PowderlyKimberly BlackwellTibor KelerJennifer GreenRenee RiggsLi-Zhen HeVenky RamakrishnaLaura VitaleBiwei ZhaoStephen A. ButlerAmy HobeikaTakuya OsadaThomas DavisTimothy ClayH. Kim Lyerly

vaccinationcancer immunotherapyvaccinesimmunomodulationcancer patientsvaccine developmentoncologycancer researchclinical immunologyimmunologyvaccine designvaccine researchtoll-like receptor stimulation

Data From Vaccine-Induced Memory Cd8 Sup + /Sup T Cells Provide Clinical Benefit in Her2 Expressing Breast Cancer: A Mouse to Human Translational Study. (2023)

Erika J. CrosbyWilliam GwinKimberly BlackwellPaul K. MarcomSerena ChangHolden T. MaeckerGloria BroadwaterTerry HyslopSungjin KimAndre RogatkoVeronica LubkovJoshua C. SnyderTakuya OsadaAmy C. HobeikaMichael A. MorseH. Kim LyerlyZachary C. Hartman

vaccinationimmune responsesmedicinevaccinesvaccine developmentvaccine trialsclinical benefitcell biologycell signalingadaptive immune systemimmunologyexperimental medicinevaccine researchbreast cancermedicinal researchvaccine efficacy

Supplementary Data From an Adenoviral Vaccine Encoding Full-Length Inactivated Human Her2 Exhibits Potent Immunogenicty and Enhanced Therapeutic Efficacy Without Oncogenicity. (2023)

Zachary C. HartmanJunping WeiTakuya OsadaOliver GlassGangjun LeiXiao-Yi YangSharon PeplinskiDong-Wan KimWenle XiaNeil SpectorJeffrey MarksWilliam BarryAmy HobeikaGayathri DeviAndrea AmalfitanoMichael A. MorseH. Kim LyerlyTimothy M. Clay

vaccinationvaccinesmedicineimmunologysupplementary datavaccine researchadenoviral vaccinevaccine efficacy

Supplementary Figure 9 From Her2 Overexpression Elicits a Proinflammatory Il-6 Autocrine Signaling Loop That is Critical for Tumorigenesis. (2023)

Zachary C. HartmanXiao-Yi YangOliver GlassGangjun LeiTakuya OsadaSandeep S. DaveMichael A. MorseTimothy M. ClayHerbert K. Lyerly

cellular therapyinsulin signalingsignaling pathwaysinflammationcell regulationcell signalingleukemianeurosciencepeptide scienceimmunologypharmacologymolecular regulationtherapeutic targetssignal transductioncytokinesgene expressionenzyme inhibitionmedicinal research

Supplementary Figure Legends From I in Vivo /I Detection of Hsp90 Identifies Breast Cancers With Aggressive Behavior. (2023)

Takuya OsadaKensuke KanekoWilliam R. GwinMichael A. MorseAmy HobeikaBrian W. PogueZachary C. HartmanPhilip F. HughesTimothy HaysteadH. Kim Lyerly

cancer biologybreast oncologytumor biologyaggressiononcologycancer researchcancer carecancer detectioncancer genomicsgeneticsaggressive behaviorradiation oncologymolecular cancerhealth sciencesbreast cancermedicinal researchcancer imagingoncogenescancer genetics

1
2
3
4
5
14
10 / page

Takuya Osada

Adjunct Associate Professor

Duke University

Affiliations

School of Medicine

Clinical Science Departments

Department of Surgery

Division of Surgical Sciences

Takuya Osada is currently serving as a Clinical Science S Adjunct Associate Professor at Duke University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Takuya Osada

Duke University

Adjunct Associate Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 4297: Cox-2/Pge2 Driven, Photoimmunotherapy-Induced Edema is Reduced by Prophylactic Nsaids in Mouse Tumor Models. Cancer Research (2026)

A Precision Ultrasound-Localized Sonoporation-Equipment (Pulse) Enabling Intratumoral Delivery for Cancer Immunotherapy. bioRxiv (Cold Spring Harbor Laboratory) (2025)

cancer immunotherapyultrasoundcancer imagingmedical ultrasoundbiomedical engineering

Abstract 1415: Reduction in Photoimmunotherapy-Induced Edema With Cox-2 Inhibition: Combatting Clinically Relevant Adverse Events Without Compromising Efficacy. Cancer Research (2024)

Gina MaMyra GordonJason LapetodaAbram LozanoChristopher M. AmanteaTakuya OsadaAmy H. Thorne

photoimmunotherapy-induced edemacancer immunotherapymedicineoncologycancer researchrelevant adverse eventsimmunologyphotomedicineclinical researchmedicinal researchtreatment options

Clinical Trials of Self-Replicating Rna-Based Cancer Vaccines. Cancer Gene Therapy (2023)

Michael A. MorseErika J. CrosbyJeremy ForceTakuya OsadaAmy C. HobeikaZachary C. HartmanPeter BerglundJonathan SmithH. Kim Lyerly

medicineoncology

Data From I in Vivo /I Detection of Hsp90 Identifies Breast Cancers With Aggressive Behavior. (2023)

Takuya OsadaKensuke KanekoWilliam R. GwinMichael A. MorseAmy HobeikaBrian W. PogueZachary C. HartmanPhilip F. HughesTimothy HaysteadH. Kim Lyerly

Data From Phase I Study Utilizing a Novel Antigen-Presenting Cell–Targeted Vaccine With Toll-Like Receptor Stimulation to Induce Immunity to Self-Antigens in Cancer Patients. (2023)

Data From Vaccine-Induced Memory Cd8 Sup + /Sup T Cells Provide Clinical Benefit in Her2 Expressing Breast Cancer: A Mouse to Human Translational Study. (2023)

Supplementary Data From an Adenoviral Vaccine Encoding Full-Length Inactivated Human Her2 Exhibits Potent Immunogenicty and Enhanced Therapeutic Efficacy Without Oncogenicity. (2023)

vaccinationvaccinesmedicineimmunologysupplementary datavaccine researchadenoviral vaccinevaccine efficacy

Supplementary Figure 9 From Her2 Overexpression Elicits a Proinflammatory Il-6 Autocrine Signaling Loop That is Critical for Tumorigenesis. (2023)

Zachary C. HartmanXiao-Yi YangOliver GlassGangjun LeiTakuya OsadaSandeep S. DaveMichael A. MorseTimothy M. ClayHerbert K. Lyerly

Supplementary Figure Legends From I in Vivo /I Detection of Hsp90 Identifies Breast Cancers With Aggressive Behavior. (2023)

Takuya OsadaKensuke KanekoWilliam R. GwinMichael A. MorseAmy HobeikaBrian W. PogueZachary C. HartmanPhilip F. HughesTimothy HaysteadH. Kim Lyerly

1
2
3
4
5
14
10 / page

Similar Faculty Members

Herbert Kim Lyerly

Institution

Duke University

immunology

oncology

Scott Joseph Antonia

Institution

Duke University

oncology

cancer research

Phyllis A. Gimotty

Institution

University of Pennsylvania

cancer research

cancer care

Amy B Heimberger

Institution

Northwestern University

brain tumor research

oncology

Zihai Li

Institution

Ohio State University

biomedical informatics

systems biology

Sherven Sharma

Institution

University of California, Los Angeles

oncology

cancer research

Eduardo M. Sotomayor, MD

Institution

University of South Florida

cellular therapy

lymphoid neoplasia

Gerard Lozanski

Institution

Ohio State University

pathology

hematological malignancies

Kazuaki Takabe

Institution

University at Buffalo

hepatology

pathology

Ash Alizadeh

Institution

Stanford University

human disease

disease classification

Similar Faculty Members

Herbert Kim Lyerly

Institution

Duke University

immunology

oncology

Scott Joseph Antonia

Institution

Duke University

oncology

cancer research

Phyllis A. Gimotty

Institution

University of Pennsylvania

cancer research

cancer care

Amy B Heimberger

Institution

Northwestern University

brain tumor research

oncology

Zihai Li

Institution

Ohio State University

biomedical informatics

systems biology

Sherven Sharma

Institution

University of California, Los Angeles

oncology

cancer research

Eduardo M. Sotomayor, MD

Institution

University of South Florida

cellular therapy

lymphoid neoplasia

Gerard Lozanski

Institution

Ohio State University

pathology

hematological malignancies

Kazuaki Takabe

Institution

University at Buffalo

hepatology

pathology

Ash Alizadeh

Institution

Stanford University

human disease

disease classification